Electrosprayed Polymer Coatings for Bone Grafts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone graft materials, particularly allografts, face challenges such as high post-implantation failure rates due to fibrotic nonunions, infections, and uneven callus formation, with existing enhancement strategies like coating with bioactive molecules and viral vectors facing issues like fibrosis, safety concerns, and production challenges.
Innovation Solution
The development of coated bone grafts using electrospray deposition to apply a polymer and therapeutic agents like BMP-2 or corilagen, creating a controlled and uniform coating that enhances osteogenic properties and reduces fibrotic tissue formation, thereby improving bone integration and healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If allograft transplantation is performed to provide immediate availability and superior mechanical properties, then the mechanical strength and availability are improved, but the failure rate due to fibrotic nonunions and infections increases
Solution Approach 1:
The patent applies composite materials by coating the allograft surface with a combination of hydrophobic polymer and hydrophilic polymer, creating a dual-layer coating system. The hydrophobic polymer layer provides structural integrity and controlled drug release, while the hydrophilic polymer layer enhances bioactivity and osteogenic differentiation. This composite coating structure allows the allograft to maintain its superior mechanical properties while adding biological functionality to reduce fibrotic nonunions and improve integration, thereby addressing the reliability issue without sacrificing mechanical strength.
2Reliability
If bone allografts are coated with bioactive molecules to enhance osteogenic properties, then bone formation is improved, but fibrotic tissue formation occurs
Solution Approach 1:
The patent employs parameter changes by carefully controlling the ratio of hydrophobic to hydrophilic polymer in the coating composition, adjusting degradation rates, and optimizing the release kinetics of bioactive molecules. By modifying these parameters, the coating delivers bioactive molecules in a controlled manner that promotes osteogenic differentiation while suppressing fibrotic tissue formation. The gradual release profile ensures sustained osteogenic stimulation without triggering excessive fibrotic response, thus resolving the contradiction between enhanced bone formation and reduced fibrosis.
3Manufacturing precision
If electrospraying is used to apply polymer and therapeutic agents onto bone graft surface, then uniform coating and controlled release are achieved, but the manufacturing complexity increases
Solution Approach 1:
The patent replaces traditional mechanical coating methods (such as dip-coating or spray-coating) with electrospraying technology. Electrospraying uses electrostatic forces to atomize the coating solution and deposit it uniformly onto the bone graft surface, achieving precise control over coating thickness and drug distribution without requiring complex mechanical positioning systems. This substitution of mechanical coating processes with electrostatic field-based deposition simplifies the manufacturing process while maintaining high coating uniformity and enabling controlled release of therapeutic agents.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The coated bone grafts demonstrate improved bone formation and integration, reduced fibrotic tissue, and enhanced biomechanical properties, leading to more effective repair and reconstruction of bone defects with controlled release of therapeutic agents.
Implementation Method 1
electrospraying a composition comprising a polymer and, optionally, an agent, particularly a therapeutic agent, onto the surface of the bone graft
Data Source
AI summary
Coated bone grafts are provided as well as methods of use thereof and methods of making. In accordance with the instant invention, methods of preparing a coated bone graft (e.g., bone allograft) are provided. In certain embodiments, the method comprises electrospraying a composition comprising a polymer and, optionally, an agent, particularly a therapeutic agent, onto the surface of the bone graft. Therapeutic agents include, without limitation: bone stimulating agents, anti-fibrotic agents, antimicrobials, anti-inflammatory agents, and pro-angiogenesis agents.